

Campral is a prescription medicine that is approved for the treatment of alcohol dependence. This eMedTV article offers an overview of Campral, including information on how it works, tips on when and how to take the drug, and possible side effects.
Diarrhea, nausea, and itching are among the most commonly reported Campral side effects. This page of the eMedTV site provides information on common and rare side effects of the drug, as well as those that should be reported to your doctor.
Weight changes may be a possible side effect of Campral (acamprosate). This eMedTV page explains that in clinical trials on Campral, weight gain and weight loss were possible side effects. This page also offers tips on how to manage your weight.
As this eMedTV page explains, some people who take Campral (acamprosate) may experience impotence, a decreased sex drive, or other Campral sexual side effects. This page explains how often these side effects occur and what to do if you develop them.
This eMedTV page explains how Campral is used for treating alcohol dependence in people who have stopped drinking and who are in counseling. This page also lists some of the possible symptoms of alcohol dependence and covers Campral uses in children.
The Campral dosage your doctor recommends will take various factors into account. This eMedTV article describes these factors and also provides tips for using this medicine. For most people, the Campral dosage is two tablets taken three times daily.
This eMedTV article explains that while there are no known Campral drug interactions at this time, interactions may be discovered in the future. This page also explains why Campral is not likely to cause negative interactions with other medicines.
You should not use Campral if you have severe liver disease. This eMedTV article provides several important Campral warnings and precautions people should be aware of before using the medication, including a list of people who should not take it.
It is possible to overdose on Campral (acamprosate). This eMedTV segment takes a detailed look at possible symptoms that may occur as a result of a Campral overdose, factors that may affect symptoms, and treatment options that are available.
This eMedTV page discusses the results of animal studies done on Campral (acamprosate) and pregnancy, explaining how the drug may cause certain birth defects. This article also explains why Campral is classified as a pregnancy Category C drug.
It is not known if Campral (acamprosate) passes through breast milk in humans. This eMedTV resource explains what to do if you are taking Campral and breastfeeding or thinking of breastfeeding. This page also covers what to discuss with your doctor.
July 2009 is the earliest date that generic Campral (acamprosate) could become available. This selection from the eMedTV Web site explains why a generic version is not currently available and explains why acamprosate is not a generic form of Campral.
| Referring Pages | Articles |